Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease

Hogervorst, E; Ribeiro, H; Molyneux, A; Budge, M; Smith, A

Journal article

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease

Abstract:: Context The pathogenesis of leukoaraiosis on computed tomographic (CT) scanning is unknown, but cerebrovascular risk factors for leukoaraiosis show overlap with those for Alzheimer disease (AD). Objective To investigate the contribution of cerebrovascular risk factors, in particular plasma total homocysteine (tHcy), to leukoaraiosis in patients with AD and controls. Design Cross-sectional case-control study. Setting Referral population to a hospital clinic and community volunteers from the Oxfordshire region in England seen between July 1, 1988, and July 1, 2000. Participants One hundred thirty-seven AD cases (104 confirmed post mortem) and 277 controls matched for age (mean ± SD, 73 ± 8 years) and sex. Main Outcome Measures Cerebrovascular risk factors and leukoaraiosis on CT scans of cases and controls; the odds ratio (OR) of having moderate to severe leukoaraiosis with higher levels of plasma tHcy and cerebrovascular risk factors such as age, sex, systolic blood pressure, smoking, diabetes mellitus, and apolipoprotein E ϵ4 genotype. Results Leukoaraiosis was more prevalent in AD cases. For a 5-µmol/L increase in tHcy levels, the OR for leukoaraiosis was 1.40 (95% confidence interval, 1.02-1.91) independent of other risk factors. The distribution pattern of leukoaraiosis was more marked in the deep white matter than in the periventricular area in individuals with elevated tHcy levels, particularly in patients with AD. Conclusions Higher tHcy levels are an independent risk factor for moderate to severe leukoaraiosis in individuals with AD and of leukoaraiosis of the deep white matter in particular. The nature of the relationship between tHcy levels and leukoaraiosis in AD requires further longitudinal and intervention studies.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Hogervorst, E., Ribeiro, H., Molyneux, A., Budge, M., & Smith, A. (2002). Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Archives of Neurology, 59(5), 787–793.

MLA Style

Hogervorst, E., et al. “Plasma Homocysteine Levels, Cerebrovascular Risk Factors, and Cerebral White Matter Changes (Leukoaraiosis) in Patients with Alzheimer Disease.” Archives of Neurology, vol. 59, no. 5, American Medical Association, 2002, pp. 787–93.

Chicago Style

Hogervorst, E, H Ribeiro, A Molyneux, M Budge, and A Smith. 2002. “Plasma Homocysteine Levels, Cerebrovascular Risk Factors, and Cerebral White Matter Changes (Leukoaraiosis) in Patients with Alzheimer Disease.” Archives of Neurology 59 (5): 787–93.
Share
Print